Industry Relations Council
APHON Industry Relations Council (IRC) participation is available to organizations and companies that support the goals and mission of APHON. Participation is available at two levels — Associate and Premier — each with its own fee structure and varying levels of opportunity to engage with the APHON audience.
Premier Level Members
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
3180 Porter Dr
Palo Alto, CA 94304
Jazz Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on identifying, developing, and commercializing innovative products for unmet medical needs. We are dedicated to living our values—with the goal of improving patients' lives.
200 Pier Four Blvd
Boston, MA 02210
Servier is a company focused on making a difference in the lives of people living with cancer. With 94 million patients treated worldwide by our medicinal products on a daily basis, we are keenly aware of our responsibilities towards patients, doctors, and healthcare professionals. They are the motivating force behind our daily drive for innovation as a provider of therapeutic progress.
6251 Greenwood Plaza Blvd. Ste 1-1
Greenwood Village, CO 80111
Silvergate Pharmaceuticals, Inc. is leading the way in the development and commercialization of innovative pediatric medications that offer dosing accuracy, safety, and availability. We are dedicated to improving the quality, accessibility, and delivery of FDA-approved medications for children and committed to making a difference in the lives of pediatric patients.
55 TW Alexander Dr.
Research Triangle Park, NC 27709
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.